Other
Shanghai Center for Disease Control and Prevention
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 6 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
67%
4 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 4
3(60.0%)
Phase 1
1(20.0%)
Phase 3
1(20.0%)
5Total
Phase 4(3)
Phase 1(1)
Phase 3(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT04220515Phase 4Completed
Inactivated Poliomyelitis Vaccine Made From Sabin Strain
Role: collaborator
NCT05415241Phase 1Unknown
Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts
Role: collaborator
NCT03561753Phase 4Completed
Pilot Clinical Trial of PRS TB Regimen I - Phase II
Role: collaborator
NCT01778595Completed
Colon Cancer Study of Fecal Samples in Shanghai, China
Role: collaborator
NCT02331823Phase 4Unknown
Research on New Regimens for Retreatment Pulmonary Tuberculosis
Role: collaborator
NCT01068015Phase 3Unknown
(Men Who Have Sex With Men) MSM Community Intervention Trial
Role: collaborator
All 6 trials loaded